Tumor-Infiltrating Lymphocytes & Tumor-Specific Antigens
ASGCT Associate Member Vincenzo Cerullo, PhD, will discuss tumor-infiltrating lymphocytes (TILs), an experimental cell therapy being developed for treating solid tumors, and tumor-specific antigens (TSAs), which can help the body make an immune response against cancer cells.
In the event’s local time
at